November 08, 2023
1 min read
Save
Orthofix launches new bioactive synthetic graft
Key takeaways:
- Orthofix announced the 510(k) clearance and full commercial launch of OsteoCove, an advanced bioactive synthetic graft.
- OsteoCove is intended for use in spine and orthopedic procedures.
Orthofix Medical Inc. announced the 510(k) clearance and full commercial launch of OsteoCove, an advanced bioactive synthetic graft, according to a company press release.
OsteoCove, which is available in both a putty and strip configuration, is intended for use in spine and orthopedic procedures.
Made to provide “superior bone-forming capabilities,” OsteoCove features a specialized granule surface topography made of B-tricalcium phosphate, hydroxyapatite and type I bovine collagen, according to the release.
Published by:
Read more about